Access all ESMO scientific and educational resources on this topic!
Recent medwireNews and resources from conferences are for ESMO Members only.
Tumour Sites: Endocrine and Neuroendocrine Cancers
Clinical Practice Guidelines
Latest ESMO videos
Featured medwireNews
Cabozantinib Shows ‘Potential’ For Radioiodine-Refractory Differentiated Thyroid Cancer
Neuroendocrine Tumour Treatments Reviewed
Gastroenteropancreatic NETs Show Late Recurrence Patterns
Dabrafenib–Trametinib Has ‘Robust Clinical Activity’ In BRAF-Mutated Anaplastic Thyroid Cancer
E-Learning
ESMO E-Learning: Overview on Management of Lung Neuroendocrine Tumours (Typical and Atypical Carcinoids)
ESMO E-Learning: Overview of the Diagnosis and Treatment of GI NETs
Meeting resources
Q&A
Presenter: George Demetri, United States; Karin Haustermans, Belgium; Juan Manuel O'Connor, Argentina; Harpreet Wasan, United Kingdom; Cathy Eng, United States
Session: Session VI: Rare GI Tumors: NETs, GISTs, and Anal cancer
Resources:
Webcast
Cases on Management Strategy in NETs
Presenter: Massimo Falconi, Italy
Session: Session VI: Rare GI Tumors: NETs, GISTs, and Anal cancer
Resources:
Slides
Webcast
O-2: Overall survival and long-term safety data from the NETTER-1 trial: 177-Lu-Dotatate vs. high-dose octreotide in patients with progressive midgut NETs
Presenter: Jonathan Strosberg, United States
Session: Session VI: Rare GI Tumors: NETs, GISTs, and Anal cancer
Resources:
Webcast
Participants Clinical Case Discussion: Glucagonoma
Presenter: L. Aleixo Barros, BR
Session: Session 6 What Do I Need to Know About…
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.